TY - JOUR T1 - To compare the incomparable: COVID-19 pneumonia and high-altitude disease JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.01362-2020 VL - 55 IS - 6 SP - 2001362 AU - Giacomo Strapazzon AU - Matthias P. Hilty AU - Pierre Bouzat AU - Lorenza Pratali AU - Hermann Brugger AU - Simon Rauch Y1 - 2020/06/01 UR - http://erj.ersjournals.com/content/55/6/2001362.abstract N2 - The coronavirus disease 2019 (COVID-19) pandemic is overwhelming healthcare systems worldwide. There is no evidence from randomised clinical trials that any potential therapy improves outcome in COVID-19 pneumonia, and therapeutic strategies have been based on a progressively increasing knowledge of the clinical presentation of the disease. Some clinicians have found the clinical features of COVID-19 pneumonia to be similar to high-altitude pulmonary oedema (HAPE) [1], and such theory has been amplified via social media. We question this relationship.COVID-19 pneumonia is a viral infection; high-altitude pulmonary oedema is a non-cardiogenic oedema. Some clinicians have found the clinical features similar. It is important to clarify such misconceptions to prevent erroneous treatment strategies https://bit.ly/2KOBi3F ER -